- Supported exchanges /
- ST /
- EGTX.ST
Egetis Therapeutics AB (publ) (EGTX ST) stock market data APIs
Egetis Therapeutics AB (publ), a pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment. Its products pipeline includes Aladote, a drug to reduce the risk of acute liver injury associated with acetaminophen/paracetamol poisoning, which is in phase IIb/III clinical trial; and Emcitate, a drug for the treatment of MCT8 deficiency, a highly debilitating rare disease with no available treatment. The company was formerly known as PledPharma AB (publ) and changed its name to Egetis Therapeutics AB (publ) in December 2020. Egetis Therapeutics AB (publ) was incorporated in 2006 and is based in Stockholm, Sweden.
Egetis Therapeutics AB (publ) Financial Data Overview
| 5.57 | |
| 5.16 | |
| - | |
| 5.25 | |
| 5.7 | |
| 4.04-9.3 | |
| 1 940 M | |
| 359 M | |
| 68 000 K | |
| -0.3 | |
| 1.43 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Egetis Therapeutics AB (publ) Fundamental Data is available in our Financial Data APIs
- Net Revenue 68 000 K
- EBITDA -299 600 000
- Earnings Per Share -1.1
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Egetis Therapeutics AB (publ) Earnings via APIs
- Latest Release 2024-11-08
- EPS/Forecast -0.3
Get Egetis Therapeutics AB (publ) End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
